Welcome to the M2012 Virtual Conference section.
Since the first microbicide conference was held in 2000 near Washington, D.C., the biennial gathering has expanded to include hundreds of top scientists in the HIV prevention field and the advocates from around the globe who have fuelled this new science.
For those of you who were unable to attend the 2012 conference in Sydney, or for those who would like to revisit key moments, we have prepared this Virtual Conference.
Watch the conference opening and closing plenary sessions below or switch to the morning plenary sessions and download the accompanying PowerPoint presentations:
Day 1: Monday: Connie Celum, Frits Van Griensven and Betsy Harold.
View the twice daily
press briefings to get the key messages M2012 speakers want you to take home.
Gina Brown, NIH OAR and Stephen Becker, Bill & Melinda Gates Foundation
closiNG PLENARY: the future of hiv biomedical prevention conferences
Salim Abdool Karim, Director, CAPRISA
Opening plenary: CAPRISA 004 two years on: What were the lessons, what are the implications?
In his keynote address, Professor Salim Abdool Karim spoke about the implications and lessons learnt two years on of the results of the landmark CAPRISA 004 trial, which provided proof of concept for ARV-based vaginal microbicides. He says:
"We have learned several lessons from CAPRISA 004 about conducting large HIV prevention trials, about women's risk factors for HIV infection and the correlates of HIV protection".
Slides to accompany the talk: CAPRISA 004 two years on
